![]()
|
Report Date : |
14.01.2008 |
IDENTIFICATION
DETAILS
|
Name : |
JORDAN SWEDEN
MEDICAL & STERILIZATION CO LTD |
|
|
|
|
Registered Office : |
Jerusalem Street,
Naour, P O Box 851831, Amman 11185 |
|
|
|
|
Country : |
Jordan |
|
|
|
|
Date of Incorporation : |
1st April 1996 |
|
|
|
|
Com. Reg. No.: |
10562, Amman |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Engaged in the manufacture
of drugs, pharmaceutical preparations, herbal and health aid supplements. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 150,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : JORDAN SWEDEN MEDICAL & STERILIZATION CO LTD
Trading As : JOSWE MEDICAL
Country of Origin : Jordan
Legal Form : Limited Liability Company
Registration Date : 1st April 1996
Commercial Registration Number : 10562, Amman
Issued Capital : JD 150,000
Paid up Capital : JD 150,000
Total Workforce : 100
Line of Business : Manufacturers of drugs, pharmaceutical preparations, herbal
and health aid supplements.
Financial Condition : Undetermined
Payments : Nothing detrimental uncovered
COMPANY NAME
JORDAN SWEDEN
MEDICAL & STERILIZATION CO LTD
TRADING AS
JOSWE MEDICAL
ADDRESS
Street : Jerusalem Street
Area : Naour
PO Box : 851831
Town : Amman 11185
Country : Jordan
Telephone : (962-6) 5859765 / 5814526 / 5728327 /
5812748
Facsimile : (962-6) 5728326 / 5816053
Email : joswe@go.com.jo
Premises
Subject operates from
a large suite of offices and a factory that are owned and located in the
Central Business Area of Amman.
KEY PRINCIPALS
·
Mohamed Ali
Mohamed Shahin Managing
Director
·
Dr Fauzi Saleh
Alawzi Director
·
Khader Nasri
Tarazi Director
·
Dr Samir
Najjar Technical
Manager
·
Dr Asa’ad A
Shahin Production
Manager
·
Dr Amjad
Zmaili Marketing
Manager
LEGAL FORM &
OWNERS
Date of Establishment : 1st
April 1996
Legal Form :
Sharikat Thet Massouliya
Mahdoudeh (Limited Liability
Company)
Commercial Reg. No. : 10562, Amman
Issued Capital : JD 150,000
Paid up Capital : JD 150,000
Name of Shareholder
(s)
·
Mohamed Ali
Mohamed Shahin
·
Dr Fauzi Saleh
Alawzi
·
Khader Nasri
Tarazi
Note to the Legal Form
A Limited Liability Company is defined in the Company Law as a company incorporated with a minimum of two and maximum of fifty shareholders, each responsible only for the liabilities of the company to the extent of their share participation in the capital of the company.
LINE OF BUSINESS
Operations : Engaged in the manufacture of drugs,
pharmaceutical preparations, herbal and health aid supplements.
Import Countries
: Europe and the United
States of America.
Subject has a
workforce of 100 employees.
FINANCIAL HIGHLIGHTS
Companies
registered in Jordan are not legally required to make their accounts public and
no financial information was released by the company or submitted by outside
sources.
BANKERS
·
Export &
Finance Bank
PO Box : 941283
Amman
Tel : (962-6) 5100200
Fax : (962-6) 5695942
PAYMENT HISTORY
No complaints
regarding subject’s payments have been reported.
Date of transaction September 2006
Credit amount 150,000
Amount overdue 0
Payment terms 60
days
Payment Method Letters
of Credit
Paying record No
Complaints
Currency US
Dollars
GENERAL COMMENTS
Opinion on the
credit figure of US$ 150,000
Established in
1996, subject is involved in the manufacture of drugs, pharmaceutical
preparations, herbal and health aid supplements.
According to local
sources, subject’s financial condition is satisfactory whilst payments are made
in a timely manner. The company’s operating history is reportedly clear and the
above credit figure is considered to be within subject’s financial means.
Maximum suggested
credit figure: US$ 150,000
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)